Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference
07 Mayo 2024 - 7:00AM
Business Wire
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage
biotechnology company committed to identifying and accelerating the
development of life-transforming therapies for patients with severe
and rare diseases, today announced that Steve Uden, M.D., Chief
Executive Officer of Rallybio, will participate in a fireside chat
at the Citizens JMP Life Sciences Conference on Tuesday, May 14,
2024 at 11:30 a.m. ET in New York, NY.
A live webcast of the fireside chat will be accessible through
the Events and Presentations section of Rallybio’s website at
www.rallybio.com. An archived replay of the webcast will be
available for 30 days following the presentation.
About Rallybio
Rallybio (Nasdaq: RLYB) is a clinical-stage biotechnology
company with a mission to develop and commercialize
life-transforming therapies for patients with severe and rare
diseases. Rallybio has built a broad pipeline of promising product
candidates aimed at addressing diseases with unmet medical need in
areas of maternal fetal health, complement dysregulation,
hematology, and metabolic disorders. The Company has two clinical
stage programs: RLYB212, an anti-HPA-1a antibody for the prevention
of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and
RLYB116, an inhibitor of complement component 5 (C5), with the
potential to treat several diseases of complement dysregulation, as
well as additional programs in preclinical development. Rallybio is
headquartered in New Haven, Connecticut. For more information,
please visit www.rallybio.com and follow us on
LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240430846888/en/
Investors Samantha Tracy Rallybio Corporation (475)
47-RALLY (Ext. 282) investors@rallybio.com
Kevin Lui Stern Investor Relations, Inc. (212) 698-8691
kevin.lui@sternir.com
Media Victoria Reynolds Mission North (760) 579-2134
rallybio@missionnorth.com
Rallybio (NASDAQ:RLYB)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Rallybio (NASDAQ:RLYB)
Gráfica de Acción Histórica
De May 2023 a May 2024